Treatment guidelines for chronic plaque psoriasis

Name: IFPA
Price range: $

13 October 2021

By IFPA

The new guidelines on systemic treatment of plaque psoriasis is now available for use by people living with psoriatic disease and healthcare providers.

Click to view the patient guide on how to use the published guidelines.

Updated guidelines on the treatment of plaque psoriasis

In November 2021, the European Guidelines Dermatology (EuroGuiDerm) team of experts updated guidelines on the systemic treatment of Psoriasis Vulgaris (chronic plaque-type of psoriasis). The recent publications are now available to open access and published by the Journal of the European Academy of Dermatology and Venereology (JEADV).

The guidelines - part 1

The first part of the guideline includes information on treatment and monitoring recommendations.

The guidelines - part 2

The second part of the guideline provides guidance for specific comorbidities – such as psoriatic arthritis and depression. It holds recommendations for treatment of people with chronic plaque psoriasis and diabetes, neurological disease and infectious diseases.